Davidson Kempner Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,857
Closed -$366K 284
2023
Q3
$366K Buy
+23,857
New +$366K ﹤0.01% 151